ASSESSMENT OF THE BRAIN DEPOSIT OF TAU 4R DETECTED BY BRAIN PET WITH 18F-PI2620 IN PROGRESSIVE SUPRANUCLEAR PALSY COMPARED TO CONTROLS WITHOUT NEURODEGENERATIVE TAUOPATHY 4R: A CLINICAL TRIAL - CUN-PETNeuroTau
Latest Information Update: 03 Sep 2025
At a glance
- Drugs PI 2620 (Primary)
- Indications Progressive supranuclear palsy
- Focus Diagnostic use
- Acronyms CUN-PETNeuroTau
Most Recent Events
- 03 Sep 2025 New trial record